Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 14/20 | 0.78 |
| ▸ | CYP1B1 | Q16678 | 14/20 | 0.78 |
| ▸ | CYP1A2 | P05177 | 12/20 | 0.78 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.78 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.78 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.78 |
| ▸ | PRKDC | P78527 | 3/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.78 |
| ▸ | PDE5A | O76074 | 1/20 | 0.78 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.78 |
| ▸ | TP53 | P04637 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.78 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.78 |
| ▸ | MAPT | P10636 | 1/20 | 0.78 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.78 |
| ▸ | HPGD | P15428 | 1/20 | 0.78 |
| ▸ | TSHR | P16473 | 1/20 | 0.78 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.78 |
| ▸ | TACR2 | P21452 | 1/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29407618 | 1.00 | CYP1A1 (0.78) | CYP1A1CYP1B1CYP1A2ABCB1ABCC1 | |
| Alpha-Naphthoflavone SCHEMBL29351090 | 0.88 | CYP1A1 (1.00) | CYP1A1CYP1B1CYP1A2ABCB1ABCC1 | |
| Alpha-Naphthoflavone SCHEMBL121594 | 0.88 | CYP1A1 (1.00) | CYP1A1CYP1B1CYP1A2ABCB1ABCC1 | |
| SCHEMBL31061133 | 0.86 | PRKDC (1.00) | CYP1A1CYP1B1CYP1A2ABCB1ABCC1 | |
| SCHEMBL4650874 | 0.85 | CYP1A1 (1.00) | CYP1A1CYP1B1CYP1A2ABCB1ABCC1 | |
| SCHEMBL14697066 | 0.85 | CYP1A1 (0.77) | CYP1A1CYP1B1CYP1A2ABCB1ABCC1 | |
| Alpha-Naphthoflavone SCHEMBL17292887 | 0.83 | CYP1A1 (0.84) | CYP1A1CYP1B1CYP1A2ABCB1ABCC1 | |
| SCHEMBL11643109 | 0.83 | MAOB (0.54) | CYP1A1CYP1B1CYP1A2ABCB1ABCC1 | |
| SCHEMBL4069839 | 0.83 | CYP1A1 (1.00) | CYP1A1CYP1B1CYP1A2ABCB1ABCC1 | |
| SCHEMBL30917246 | 0.83 | CYP1A1 (1.00) | CYP1A1CYP1B1CYP1A2ABCB1ABCC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12453713-B2 | Liquid formulation to treat a corneal tissue | VISION ENGINEERING ITALY SRL (IT) | 2025-10-28 | — | — | US | disclosed |
| US-20230131004-A1 | LIQUID FORMULATION, IN PARTICULAR TO TREAT A CORNEAL TISSUE | VISION ENGINEERING ITALY SRL (IT) | 2023-04-27 | — | — | US | disclosed |
| US-20210069230-A1 | SYNERGISTIC DRUG COMBINATIONS PREDICTED FROM GENOMIC FEATURES AND SINGLE-AGENT RESPONSE PROFILES | THE BROAD INSTITUTE, INC. (US) | 2021-03-11 | — | — | US | disclosed |
| WO-2018234421-A1 | METHOD OF MODULATING IMMUNE CELLS | OSLO UNIVERSITETSSYKEHUS HF (NO) | 2018-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210069230-A1 | SYNERGISTIC DRUG COMBINATIONS PREDICTED FROM GENOMIC FEATURES AND SINGLE-AGENT RESPONSE PROFILES | ABCC1, TSG101, BRCA1 | CYP1A1 4156/4885CYP1B1 4407/4885CYP1A2 3757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.